Development of pharmacovigilance programme for adverse drug reaction monitoring in psychiatry and tuberculosis

dc.contributor.guide	Tatke, Pratima and Kshirsagar, Nilima
dc.coverage.spatial	Pharmaceutical Sciences
dc.creator.researcher	Bandekar, Mitali
dc.date.accessioned	2016-10-13T04:57:40Z
dc.date.available	2016-10-13T04:57:40Z
dc.date.awarded	n.d.
dc.date.completed	2012
dc.date.registered	n.d.
dc.description.abstract	Abstract not available newline newline
dc.description.note	Bibliography p. 246-251, Appendix p. 252-290
dc.format.accompanyingmaterial	None
dc.format.dimensions	-
dc.format.extent	x, 290p., viii
dc.identifier.uri	http://hdl.handle.net/10603/109836
dc.language	English
dc.publisher.institution	C U Shah College of Pharmacy
dc.publisher.place	Mumbai
dc.publisher.university	SNDT Womens University
dc.relation	No. of references 77
dc.rights	university
dc.source.university	University
dc.subject.keyword	Pharmacovigilance System, Drug Reaction, Visceral Leishmaniasis, Psychiatry, Tuberculosis, Highly Active Anti Retroviral Therapy,Psychotropic drug therapy, Kala-Azar
dc.title	Development of pharmacovigilance programme for adverse drug reaction monitoring in psychiatry and tuberculosis
dc.title.alternative	-
dc.type.degree	Ph.D.